Back to Blog

Women in Listed Derivatives Announces 2019 North American Board
11/28/2018

Caroline Gillard

Women in Listed Derivatives Announces the 2019 North American Board

CHICAGO (November 28, 2018) – Women in Listed Derivatives (WILD), an organization which promotes career advancement and professional relationship-building among women in the OTC & Listed Derivatives Industry, today announced new additions to its board of directors.

 

The North American chapter of WILD announced that Cathey Curley, Lead Business Analyst at Nuveen Investments, Simta Gupta, Commodity Risk Manager at BP, Denise Knabjian, First Vice President of Process Innovation at OCC, Mary Mapes, Manager of Global Operations at CME, Erin Preston, Chief Compliance Officer and General Counsel for Dash Financial Services LLC, and Diane Saucier, Senior Solutions Marketing Manager, Financial Service, at Hitachi Vantara, will fill six open board seats. They join sitting board members Katie Cleland, Elizabeth Cook, Caroline Gillard, Ellen Greene and Leslie Sutphen.

 

“We’re excited to welcome our new board members to WILD’s board of directors, and look forward to what each of these exceptional individuals will bring to our organization,” said Leslie Sutphen, co-founder and President of WILD. “We also want to thank Karen Chhokar, Natalie Oblazny and Adrienne White for their time and invaluable contributions to WILD while on our board of directors.”

 

The 2019 board of directors will oversee events, membership, mentorship programs and charitable activities as well as look for new ways to promote the advancement of women in the industry. Board members serve two-year terms on a staggered basis.

 

WILD began informally in 2009 and first established its board in 2012. As a non-profit, WILD promotes career advancement and professional relationship-building among women in the OTC & Listed Derivatives Industry through social and educational events and whose mission it is to highlight and learn from industry role models, encourage career development and support the advancement of women in OTC & Listed Derivatives. More information can be found at www.womeninlistedderivatives.org.

 

Media Contact

Caroline Gillard

carolinegillard5@gmail.com

(708) 860-9954